The link between diabetes and atherosclerosis
L La Sala, F Prattichizzo… - European journal of …, 2019 - journals.sagepub.com
Atherosclerosis is one of the main complications of diabetes involving multiple causative
factors. Dysfunction of the vascular endothelium is a hallmark of most conditions that are …
factors. Dysfunction of the vascular endothelium is a hallmark of most conditions that are …
Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review
In the light of growing global epidemic of type 2 diabetes mellitus (T2DM), significant efforts
are made to discover next-generation biomarkers for early detection of the disease. Multiple …
are made to discover next-generation biomarkers for early detection of the disease. Multiple …
Early diagnosis of gestational diabetes mellitus using circulating microRNAs
L Yoffe, A Polsky, A Gilam, C Raff… - European journal of …, 2019 - academic.oup.com
Abstract Design Gestational diabetes mellitus (GDM) is one of the most common pregnancy
complications and its prevalence is constantly rising worldwide. Diagnosis is commonly in …
complications and its prevalence is constantly rising worldwide. Diagnosis is commonly in …
MicroRNAs as biomarkers of diabetic retinopathy and disease progression
B Martinez, PV Peplow - Neural regeneration research, 2019 - journals.lww.com
Diabetes mellitus, together with its complications, has been increasing in prevalence
worldwide. Its complications include cardiovascular disease (eg, myocardial infarction …
worldwide. Its complications include cardiovascular disease (eg, myocardial infarction …
MicroRNAs and other non-coding RNAs in adipose tissue and obesity: emerging roles as biomarkers and therapeutic targets
S Lorente-Cebrián, P González-Muniesa… - Clinical …, 2019 - portlandpress.com
Obesity is a metabolic condition usually accompanied by insulin resistance (IR), type 2
diabetes (T2D), and dyslipidaemia, which is characterised by excessive fat accumulation …
diabetes (T2D), and dyslipidaemia, which is characterised by excessive fat accumulation …
miR-223-3p as a potential biomarker and player for adipose tissue dysfunction preceding type 2 diabetes onset
J Sánchez-Ceinos, OA Rangel-Zuñiga… - … Therapy-Nucleic Acids, 2021 - cell.com
Circulating microRNAs (miRNAs) have been proposed as biomarkers for type 2 diabetes
(T2D). Adipose tissue (AT), for which dysfunction is widely associated with T2D …
(T2D). Adipose tissue (AT), for which dysfunction is widely associated with T2D …
Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients
G Mahjoob, Y Ahmadi, H Fatima rajani… - Journal of Clinical …, 2022 - Wiley Online Library
Background Type 2 diabetes mellitus (T2DM) is an increasing metabolic disorder mostly
resulting from unhealthy lifestyles. T2DM patients are prone to develop heart conditions …
resulting from unhealthy lifestyles. T2DM patients are prone to develop heart conditions …
Circulating miRNAs in women with polycystic ovary syndrome: a longitudinal cohort study
PB Udesen, AE Sørensen, R Svendsen, NLS Frisk… - Cells, 2023 - mdpi.com
Background: Women with polycystic ovary syndrome (PCOS) often change their metabolic
profile over time to decrease levels of androgens while often gaining a propensity for the …
profile over time to decrease levels of androgens while often gaining a propensity for the …
[HTML][HTML] microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: a systematic review and pathway analysis
Background Cardiotoxicity is a common and serious adverse effect of anthracycline therapy
in breast cancer patients. The current criteria for cardiotoxicity are based on imaging and …
in breast cancer patients. The current criteria for cardiotoxicity are based on imaging and …
[HTML][HTML] MicroRNA and diabetic retinopathy—biomarkers and novel therapeutics
Z Smit-McBride, LS Morse - Annals of translational medicine, 2021 - ncbi.nlm.nih.gov
Diabetic retinopathy (DR) accounts for~ 80% of legal blindness in persons aged 20–74
years and is associated with enormous social and health burdens. Current therapies are …
years and is associated with enormous social and health burdens. Current therapies are …